The Atlantic Study: A Randomized, Open-Label Strategic Study to Evaluate the Safety and Efficacy of 3 Different Convergent and Divergent Drug Combination Therapies in Anti-Retroviral Naive HIV-1 Infected Patients with CD4+ Counts above 200/mm3

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/97 → 11/8/10

Funding

  • Academic Medical Centre at the University of Amsterdam (Prot# 57, Version 3.0 // Prot# 57, Version 3.0)
  • Bristol-Myers Squibb Pharmaceutical Research Institute (Prot# 57, Version 3.0 // Prot# 57, Version 3.0)